Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$506M |
| 2 |
Microsoft
MSFT
|
+$355M |
| 3 |
ExxonMobil
XOM
|
+$267M |
| 4 |
Amazon
AMZN
|
+$257M |
| 5 |
Meta Platforms (Facebook)
META
|
+$245M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian National Railway
CNI
|
+$86.2M |
| 2 |
Suncor Energy
SU
|
+$80.1M |
| 3 |
SE
Spectra Energy Corp Wi
SE
|
+$79.6M |
| 4 |
STJ
St Jude Medical
STJ
|
+$63.5M |
| 5 |
TC Energy
TRP
|
+$59.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.61% |
| 2 | Healthcare | 15% |
| 3 | Consumer Discretionary | 10.63% |
| 4 | Communication Services | 10.48% |
| 5 | Industrials | 10.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SSRI
1526
DELISTED
Silver Standard Resources
SSRI
| $2.1M | ﹤0.01% |
197,511
+3,500
| +2% | +$37K |
|
|
RWT
1527
Redwood Trust
RWT
$574M
| $2.1M | ﹤0.01% |
126,100
| – | – |
|
1528
Varex Imaging
VREX
$778M
| $2.08M | ﹤0.01% |
+62,040
| New | +$1.96M |
|
1529
Mativ Holdings
MATV
$706M
| $2.08M | ﹤0.01% |
50,300
| – | – |
|
1530
Progress Software
PRGS
$1.78B
| $2.08M | ﹤0.01% |
71,700
| – | – |
|
|
AVXS
1531
DELISTED
AveXis, Inc. Common Stock
AVXS
| $2.08M | ﹤0.01% |
27,400
+800
| +3% | +$49.5K |
|
|
EGOV
1532
DELISTED
NIC Inc
EGOV
| $2.08M | ﹤0.01% |
103,000
| – | – |
|
|
HSNI
1533
DELISTED
HSN, Inc.
HSNI
| $2.07M | ﹤0.01% |
55,900
+1,600
| +3% | +$57.3K |
|
1534
Agree Realty
ADC
$9.22B
| $2.07M | ﹤0.01% |
43,182
+1,000
| +2% | +$47.4K |
|
1535
E.W. Scripps
SSP
$309M
| $2.07M | ﹤0.01% |
88,316
| – | – |
|
|
TPC
1536
Tutor Perini Cor
TPC
$5.18B
| $2.06M | ﹤0.01% |
64,900
+1,600
| +3% | +$47.5K |
|
|
NP
1537
DELISTED
Neenah, Inc. Common Stock
NP
| $2.06M | ﹤0.01% |
27,600
| – | – |
|
|
SPNC
1538
DELISTED
Spectranetics Corp
SPNC
| $2.06M | ﹤0.01% |
70,700
+2,400
| +4% | +$64K |
|
1539
Gibraltar Industries
ROCK
$1.45B
| $2.06M | ﹤0.01% |
49,900
| – | – |
|
1540
AMERISAFE
AMSF
$522M
| $2.05M | ﹤0.01% |
31,600
| – | – |
|
|
UNT
1541
DELISTED
UNIT Corporation
UNT
| $2.05M | ﹤0.01% |
84,800
+2,500
| +3% | +$63.9K |
|
1542
Inogen
INGN
$160M
| $2.05M | ﹤0.01% |
26,400
| – | – |
|
|
ENV
1543
DELISTED
ENVESTNET, INC.
ENV
| $2.05M | ﹤0.01% |
63,400
| – | – |
|
|
LNW
1544
DELISTED
Light & Wonder
LNW
| $2.05M | ﹤0.01% |
86,500
| – | – |
|
1545
Supernus Pharmaceuticals
SUPN
$2.74B
| $2.04M | ﹤0.01% |
65,300
+2,100
| +3% | +$56.3K |
|
1546
Amkor Technology
AMKR
$13.1B
| $2.04M | ﹤0.01% |
176,300
+5,300
| +3% | +$54.7K |
|
|
FSP
1547
Franklin Street Properties
FSP
$45.3M
| $2.04M | ﹤0.01% |
167,863
+3,700
| +2% | +$45.8K |
|
|
MDC
1548
DELISTED
M.D.C. Holdings, Inc.
MDC
| $2.04M | ﹤0.01% |
85,453
+2,520
| +3% | +$56.8K |
|
|
KYNB
1549
Kyntra Bio
KYNB
$28.2M
| $2.04M | ﹤0.01% |
3,304
+104
| +3% | +$63.3K |
|
1550
Puma Biotechnology
PBYI
$449M
| $2.04M | ﹤0.01% |
54,730
+1,100
| +2% | +$40.1K |
|
Similar funds
Swiss National Bank's Q1 2017 Portfolio in Review
As of Q1 2017, Swiss National Bank held 2,570 positions worth $80.4B, up 27% from $63.4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Swiss National Bank deployed $13.1B of net new capital in Q1 2017, opening 6 new positions and adding to 1,330 existing holdings. Its largest new stake was Qiagen: 988,583 shares worth $30.5M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Canadian National Railway, an estimated $86.2M trimmed.
- Swiss National Bank's largest Q1 2017 buy was Qiagen: 988,583 shares worth $30.5M.
- Swiss National Bank added most to Apple in Q1 2017, an estimated $506M increase.
- Swiss National Bank's biggest Q1 2017 reduction was Canadian National Railway, cutting an estimated $86.2M.
- Swiss National Bank fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $79.6M.
- Swiss National Bank's ten largest holdings make up 17% of its $80.4B portfolio in Q1 2017.
- Swiss National Bank opened 6 new positions and closed 36 in Q1 2017.
- Swiss National Bank's portfolio value rose 27% quarter-over-quarter to $80.4B.
Based on Swiss National Bank's 13F filing for Q1 2017, filed 4 May 2017.